As a young, dynamic and creative molecular diagnostics company, we have specialized in simple and rapid solutions for the diagnosis of severe infectious diseases in hospitalized patients. We help to combat infections effectively and detect antibiotic resistance at an early stage.
Curetis to Present at Key Investor and Scientific Conferences in the Fourth Quarter 2017
MGI and Curetis to Collaborate on NGS-based Infectious Disease Diagnostics
European Meeting on Molecular Diagnostics - Noordwijk, Netherlands - October 11 to 13, 2017
CRIOAC, 3ème Congrès des Centres de Référence des Infections Ostéo-Articulaires Complexes - Tours, France - October, 19 to 20, 2017